Market Research Report
Global 3D Cell Culture Market Forecast 2019-2027
|Published by||Inkwood Research||Product code||910169|
|Published||Content info||180 Pages
Delivery time: 2-3 business days
|Global 3D Cell Culture Market Forecast 2019-2027|
|Published: September 6, 2019||Content info: 180 Pages||
The global 3D cell culture market is estimated to project a CAGR of 12.06% during the forecast period 2019-2027. An increase in demand for transplanting organs and tissue engineering for the treatment of chronic diseases is expected to 3D cell culture market.
The growing demand for 3D cell culture platforms, technological advancements, increasing focus on regenerative medicine, rising investments in cell-based research, are the factors estimated to contribute to the growth of global 3D culture cell market. The shift from conventional cell culture method to 3D cell culture technique due to its expanding application in biological research is estimated to drive the growth of the market. On the other hand, the expenditure with regards to the implementation of 3D cell culture, dearth of skilled professionals, and inconsistency in results are estimated to restrain the growth of the market.
Geographically, the global 3D cell culture market is segmented into four regions, namely North America, Europe, Asia-Pacific, and Rest of the world. The Asia-Pacific is estimated to be the fastest-growing market during the forecast period. This is attributed to the developing infrastructure and the rising awareness of technologies in health care.
Some of the major players of the market are Insphero, 3D Biotek LLC, Emulate, Lonza Group Ag, Merck KGaA, Becton, Dickinson and Company, GE Healthcare, and Corning Inc., among others.